Back to Companies
GENELUX Corp
GNLXNasdaqCIK: 0001231457
Over the 39 most recent insider filings, GENELUX Corp (GNLX) has seen activity from 11 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $276.8K sold, net sales of $276.8K. Zindrick Thomas (President and CEO) is the most active by dollar volume, and the single largest transaction was $16.8M by Zindrick Thomas. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$26.6M
Purchases
$0
Sales
$276.8K
Unique Insiders
11
Recent Insider Trades
39 loaded
| Jul 2 | GNLX GENELUX Corp | Smither John W | Director | Sell | $34.9K |
| Jun 18 | GNLX GENELUX Corp | Yu Yong | Chief Scientific Officer | Grant | $0 |
| Jun 18 | GNLX GENELUX Corp | Zindrick Thomas | President and CEO | Grant | $0 |
| Jun 18 | GNLX GENELUX Corp | Tyree James L | Director | Grant | $95.6K |
| Jun 18 | GNLX GENELUX Corp | Cappello Joseph | Chief Technical Officer | Grant | $0 |
| Jun 18 | GNLX GENELUX Corp | Thomas John | Director | Grant | $95.6K |
| Jun 18 | GNLX GENELUX Corp | Mirabelli Mary | Director | Grant | $95.6K |
| Jun 18 | GNLX GENELUX Corp | Pulisic Matthew | Chief Financial Officer | Grant | $0 |
| Jun 18 | GNLX GENELUX Corp | Smither John W | Director | Grant | $95.6K |
| Jun 18 | GNLX GENELUX Corp | Groen Eric | General Counsel | Grant | $0 |
| Jun 4 | GNLX GENELUX Corp | Smalling Ralph | Head of Regulatory | Sell | $563 |
| Jun 2 | GNLX GENELUX Corp | Thomas John | Director | Sell | $29.8K |
| May 12 | GNLX GENELUX Corp | Yu Yong | Chief Scientific Officer | Sell | $1.8K |
| May 12 | GNLX GENELUX Corp | Smalling Ralph | Head of Regulatory | Sell | $804 |
| May 12 | GNLX GENELUX Corp | Cappello Joseph | Chief Technical Officer | Sell | $1.8K |
| May 12 | GNLX GENELUX Corp | Zindrick Thomas | President and CEO | Sell | $8.2K |
| Mar 26 | GNLX GENELUX Corp | Zindrick Thomas | President and CEO | Sell | $8.7K |
| Mar 26 | GNLX GENELUX Corp | Yu Yong | SVP, Clinical Development | Sell | $2.2K |
| Mar 26 | GNLX GENELUX Corp | Cappello Joseph | Chief Technical Officer | Sell | $2.2K |
| Mar 26 | GNLX GENELUX Corp | Smalling Ralph | Head of Regulatory | Sell | $1.4K |
| Mar 3 | GNLX GENELUX Corp | Thomas John | Director | Sell | $29.0K |
| Jan 7 | GNLX GENELUX Corp | Litten Jason | Chief Medical Officer | Other | $0 |
| Jan 7 | GNLX GENELUX Corp | Litten Jason | Chief Medical Officer | Award | $1.3M |
| Dec 2 | GNLX GENELUX Corp | Thomas John | Director | Sell | $50.0K |
| Sep 3 | GNLX GENELUX Corp | Zindrick Thomas | President and CEO, Director | Award | $16.8M |
| Sep 3 | GNLX GENELUX Corp | Cappello Joseph | Chief Technical Officer | Award | $2.7M |
| Sep 3 | GNLX GENELUX Corp | Yu Yong | SVP, Clinical Development | Award | $3.6M |
| Sep 3 | GNLX GENELUX Corp | Smalling Ralph | Head of Regulatory | Grant | $77.7K |
| Aug 29 | GNLX GENELUX Corp | Smither John W | Director | Grant | $104.0K |
| Aug 29 | GNLX GENELUX Corp | Smalling Ralph | Head of Regulatory | Grant | $126.6K |
| Aug 29 | GNLX GENELUX Corp | Mirabelli Mary | Director | Grant | $104.0K |
| Aug 29 | GNLX GENELUX Corp | Thomas John | Director | Grant | $104.0K |
| Aug 29 | GNLX GENELUX Corp | Cappello Joseph | Chief Technical Officer | Grant | $518.7K |
| Aug 29 | GNLX GENELUX Corp | Tyree James L | Director | Grant | $104.0K |
| Aug 29 | GNLX GENELUX Corp | Yu Yong | SVP, Clinical Development | Grant | $489.7K |
| Dec 9 | GNLX GENELUX Corp | Smalling Ralph | Head of Regulatory | Sell | $8.7K |
| Dec 11 | GNLX GENELUX Corp | Zindrick Thomas | President and CEO | Sell | $66.4K |
| Dec 11 | GNLX GENELUX Corp | Cappello Joseph | Chief Technical Officer | Sell | $14.4K |
| Dec 11 | GNLX GENELUX Corp | Yu Yong | SVP, Clinical Development | Sell | $16.0K |
39 filings